Company intelligence / Profile preview

Companion Spine

New York, New York, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Companion Spine has launched or acquired a suite of CE-marked and US FDA-cleared minimally invasive implants and diagnostic systems for lumbar and cervical spinal disorders, including devices with long clinical histories such as Coflex and innovative implants such as DIAM and LISA. Regulatory and commercial launch expansion is ongoing, with strong supporting clinical evidence for patient outcomes, including over 150 peer-reviewed publications and >90% patient satisfaction for Coflex.[4][1][5]

Therapeutic areas: NeurologyRheumatology
Modalities: DeviceNon-pharmacological therapySurgical technology
Industry: Implantable Medical Devices

Partnerships

Viscogliosi Brothers (founding investor, strategic partner)[1]

Beyond the preview

Go deeper on Companion Spine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Companion Spine.

Explore the full profile